BioNet-Asia Co., Ltd.

Press Release

      April 3, 2012

      KMUTT and Biotec join hands with BioNet-Asia on quality control for vaccine development

      January 11, 2012

      BioNet-Asia to license recombinant pertussis strain

      Febuary 21, 2011

      BioNet-Asia to enter development of Dengue vaccine

      January 21, 2011

      Thailand to accelerate vaccine development and production capability

      January 15, 2009

      First R&D Centre to develop recombinant acellular pertussis vaccine in Thailand opens

Symposium on Building Vaccine Development Capacity in Thailand

On the occasion of its 10^th anniversary, BioNet organized a Vaccine Symposium in collaboration with the National Vaccine Committee Office, Thailand on January 21, 2011.

      o Academic partnerships for developing conjugate vaccines, the Cape Town experience
      (Prof.Neil Ravenscroft, University of Cape Town)

      o New approaches to Dengue vaccine development
      (Assoc.Prof.Nopporn Sittisombut, Chiang Mai University)

      o Role of NVCO in supporting vaccine development and production in Thailand
      (Dr.Charung Muangchana, National Vaccine Institute)

      o Vaccine R&D opportunities for developing countries
      (Dr.Jean O.A. Petre, Technical and Scientific Director, BioNet-Asia)

      o แนวทางการพัฒนานักวิจัยเพื่อรองรับความต้องการของภาคอุตสาหกรรมในอนาคต
      (Prof.Dr.Amaret Bhumiratana, The Thailand Research Fund (TRF))

      o สิทธิประโยชน์และการส่งเสริมการลงทุนสำหรับกิจการวิจัยและพัฒนา
      (Dr.Ratchanee Wattanawisitporn, Office of the Board of Investment)

--------------------------------------------------------

For further information, please contact:
BioNet-Asia Co., Ltd. Tel: +66 (0) 2361 8110
Sininat Maungyim
E-mail: info@bionet-asia.com